Last edition
News about "biotech fundraising"
Nektar Therapeutics Closes USD 373.8 Million Public Offering
Nektar Therapeutics completes USD 373.8 million public offering, including full exercise of underwriters’ option to purchase additional shares.
Biotech Fundraising | 24/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members